Related Experiment Videos
[Metastatic enhancement: biological mechanisms and therapeutic implications]
1Laboratoires Glaxo, centre de recherches France, Les Ulis.
Abstract:
In experimental models chemotherapeutic agents enhance spontaneous metastases. Vascular toxicity and myelotoxicity may account for this phenomenon. However, drugs may act directly on tumor cells. Clonogenic resistant cells are involved in the metastatic process facilitation. Fundamental biological mechanisms are evoked to explain these observations. Mutagenicity and its consequences on gene expression or regulation are another hypothesis. Clinical investigations are necessary to confirm the results obtained from animal models.
Insights
Chemotherapeutic agents may unexpectedly promote cancer metastasis in experimental models. This effect could stem from vascular or bone marrow toxicity, or direct impacts on drug-resistant tumor cells.
Area of Science:
- Oncology
- Cancer Biology
- Pharmacology
Context:
- Chemotherapeutic agents are standard cancer treatments.
- Experimental models suggest a paradoxical effect of chemotherapy.
- Metastasis remains a primary cause of cancer mortality.
Purpose:
- To explore the mechanisms by which chemotherapeutic agents may enhance spontaneous metastases in experimental models.
- To investigate the roles of vascular toxicity, myelotoxicity, and tumor cell-specific effects.
- To consider the contribution of clonogenic resistant cells and mutagenicity.
Summary:
- Chemotherapy can enhance spontaneous metastases in preclinical studies.
- Potential mechanisms include vascular and bone marrow toxicity.
- Direct effects on clonogenic resistant tumor cells and mutagenicity are also implicated.
Impact:
- Highlights the need for further clinical investigation into chemotherapy's role in metastasis.
- Suggests potential therapeutic strategies to mitigate chemotherapy-induced metastasis.
- Underscores the complexity of chemotherapy's effects beyond direct tumor cell killing.